Kawasaki disease: management guidelines.
D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000517:prevention & control; D004341:Drug Evaluation; D006801:Humans; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D005719:gamma-Globulins / Q000627:therapeutic use
D005719:gamma-Globulins; D001241:Aspirin